Zatonav 300 mg FC tablets

Zatonav 300 mg FC tablets

S4
PDF Leaflet Revision Date: 08 August 2025

API: Ritonavir | Company: Viatris Healthcare

Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of HIV-1 infection in combination with other antiretroviral medicines.

Dosage (summary)

One tablet once daily with food.

Special Populations

  • Elderly
  • Renal impairment
  • Hepatic impairment

Pregnancy & Breastfeeding

Contraindicated in pregnancy and lactation; safety not established.

Key Drug Interactions

  • Rifampicin
  • Digoxin
  • Amiodarone
  • Sedative hypnotics
  • St. John's Wort

Contraindications

  • Hypersensitivity to atazanavir or ritonavir
  • Moderate to severe hepatic impairment
  • Concomitant use with certain medications

Common side effects

  • Jaundice
  • Rash
  • Nausea
  • Diarrhea
  • Headache

Counselling Points

  • Take with food
  • Monitor for jaundice
  • Avoid certain medications
  • Do not breastfeed

Serious warnings

  • Serious drug interactions
  • Potential for hepatic toxicity
  • Risk of pancreatitis
Important Disclaimer

The Zatonav 300 mg FC tablets professional information leaflet below is the property of Viatris Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites